New Jersey A 1405: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2024-01-09)

State: New Jersey · Session: 221 · Bill: A 1405

Subjects: PHARMACEUTIC

Sponsors: Haider, Shama A.

View New Jersey A 1405 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.